HomeMiningLotus Resources (ASX:LOT)

Kayelekera Project Faces Production Delays and US$7 Million Liability Risk

Mining By Maxwell Dee 4 min read

Lotus Resources confirms material operational setbacks at Kayelekera uranium project, including acid plant damage and production delays impacting offtake commitments. The company remains suspended pending critical funding arrangements.

  • Acid plant damage causes production delays
  • Inability to meet 2H 2026 offtake obligations
  • External funding required for financial viability
  • Process optimisation program underway with limited cost impact
  • Off-specification uranium product sales under consideration

Acid Plant Damage Triggers Production Setbacks

Lotus Resources (ASX:LOT) has confirmed significant damage to the acid plant at its Kayelekera uranium project during hot commissioning, which has led to delays in production and disrupted its ability to meet contracted offtake obligations for the second half of 2026. The company first became aware of the damage on 17 June 2026, with rectification plans underway but not yet complete. This disruption has forced a temporary production suspension and has materially affected operational timelines.

Offtake Obligations and Financial Exposure

Due to the production delays, Lotus acknowledges it will be incapable of meeting its initial offtake commitment to deliver 1.01 million pounds of U3O8 in 2H CY2026. While the company estimates a maximum potential liability of approximately US$10 million if no deliveries occur and no deferrals are agreed, it does not consider this figure material in isolation, emphasizing ongoing negotiations with customers to defer deliveries. As of the latest update, 0.11 million pounds have been deferred, 0.20 million pounds are forecast for delivery, and 0.70 million pounds remain under negotiation.

Funding Critical to Ongoing Viability

Lotus Resources remains in a voluntary suspension of trading until it finalises a strategic funding package deemed critical to its financial viability and the continued operation of Kayelekera. The company holds a cash balance of US$26 million as of 22 June 2026 but requires external funding, potentially through equity or quasi-equity instruments, to manage liabilities and support operational restart. The funding process is contingent on demonstrating acid plant commissioning, a pathway to steady-state production, and resolution of offtake commitments.

Process Optimisation Program and Metallurgical Review

In parallel, Lotus has initiated a US$3.1 million Process Optimisation Program aimed at transitioning from restart to steady-state production, focusing on plant reliability, maintenance, process control, recovery improvements, and laboratory capability. Approximately US$1.4 million has been spent to date, with the program expected to complete by the end of September 2026. Separately, a metallurgical accounting and reconciliation review by Novamet is nearing finalisation to reassess and potentially restate certain processing data, including recoveries previously retracted for the period to December 2025. However, the company does not consider these adjustments material to its production metrics or financial condition.

Product Quality and Off-Specification Uranium

Of the 332,000 pounds of U3O8 produced at Kayelekera so far, 115,000 pounds have been classified as on-specification, 124,000 pounds remain subject to final assay and classification, and 93,000 pounds are off-specification. Lotus is exploring options to sell the off-specification product, including blending and price discounting, and does not anticipate these sales will materially impact its financial position. The company expects to receive final assay results for the pending product by mid to late August 2026.

Accreditation and Shipping Route Adjustments

Lotus is not actively pursuing accreditation with ConverDyn and Cameco at present, following a strategic decision influenced by a change in shipping routes from Dar Es Salaam to Walvis Bay. This new route offers more direct access to Europe, where Orano CE is located, but complicates shipments to North America, increasing transit times and working capital requirements. Despite ceasing active accreditation efforts, discussions with these converters have not formally ended, and the company maintains delivery flexibility through Orano CE accounts.

Bottom Line?

Lotus Resources faces a critical juncture as it navigates operational setbacks and funding challenges, with the timing and success of its strategic capital raise and production ramp-up pivotal for its near-term trajectory.

Questions in the middle?

  • Will Lotus secure the necessary funding to exit suspension and resume steady-state production by late 2026?
  • How will negotiations with offtake customers evolve amid ongoing delivery uncertainties?
  • What impact will the metallurgical data reassessment have on future production guidance and investor confidence?